Heimdall Insights

Global Hyperkalemia Treatment Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Hyperkalemia Treatment Market was valued at $2.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 13.5% CAGR, to an estimated market size of $4.1 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global hyperkalemia treatment market encompasses pharmaceutical therapies and clinical interventions designed to manage and reduce elevated potassium levels (typically above 5.0 mmol/L) in the blood. The scope includes potassium binders, diuretics, and acute pharmacological interventions primarily used for patients with chronic kidney disease (CKD), heart failure, and diabetes, while excluding general dietary supplements not indicated for clinical hyperkalemia.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Hyperkalemia Treatment Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Potassium Binders
  • Diuretics
  • Dialysis & Acute Therapies
  • Other Pharmacological Agents